← Eichor
Study identifier: NCT05474963 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital

Condition: SSNHL(Sudden Sensory Neural Hearing Loss) · Sudden Hearing Loss · Hearing Loss, Idiopathic Sudden Sensorineural  ·  Sponsor: Wonju Severance Christian Hospital

PhaseN/A
Planned participants1000
Who can joinAll sexes, 20 Years to 100 Years
Healthy volunteersNo

About this study

This study is to build a cohort of sudden sensorineural hearing loss (SSNHL) patients. When the patient visited the Department of otolaryngology clinic for hearing loss, we can diagnose the SSNHL following the result of pure tone audiometry and the history of the patient. The cohort is a system that tracks the hearing recovery status, timing, and degree of recovery of patients who received cocktail therapy with or without high-dose steroids, vasodilators, antiviral agents, and intratympanic steroid injections, satellite ganglion block, and hyperbaric oxygen therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Tae Hoon Kong, MD, PhD  ·  +821044650635  ·  cochlear84@yonsei.ac.kr

Always discuss trial participation with your own doctor first.

Locations (1)

Yonsei University Wonju Severance Christian HospitalWŏnju, Gangwon-do, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05474963